Background Antimicrobial resistance (AMR) is a growing global health crisis and is particularly relevant to people living ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Background Smoking has been considered an important risk factor for idiopathic pulmonary fibrosis (IPF) incidence. However, there are no population-based large-scale studies demonstrating the effects ...

This document is the result of a joint initiative by the British Thoracic Society (BTS) and the Society of Cardiothoracic Surgeons of Great Britain and Ireland (SCTS) to produce detailed ...

Background to the project Chronic obstructive pulmonary disease (COPD) is a common condition 1 with acute exacerbations of COPD (AECOPD) or ‘lung attacks’ causing 12% of acute admissions and being ...

Systemic lupus erythematosus (SLE), an autoimmune disorder which primarily affects women (10:1 female to male ratio), may affect virtually any organ.1 Predominant manifestations include non-deforming ...

Introduction Paediatric sleep diagnostics uses complex multi-channel tests in specialised centres, limiting access, delaying diagnosis and management. Children with neurodevelopmental disorders, at ...

The 2020 coronavirus pandemic has been particularly difficult for people living with chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD). COPD is associated with ...

COPD is a progressive disease where airway inflammation plays an important part. Previously, there were large expectations that regular anti-inflammatory treatment with inhaled corticosteroids (ICS) ...

Background Coding practices impact the recorded prevalence of disease. Sepsis, most commonly caused by pneumonia, remains a common cause of mortality worldwide. In April 2017, NHS Digital issued new ...

Background Up to 50% of patients suffering acute pulmonary embolism (PE) demonstrate impaired pulmonary vascular recovery at follow up despite optimal anticoagulation, impacting negatively on ...

Results Of 190 participants included in the analysis, 153 (80%) had a positive response to mepolizumab [mean age at enrolment of 52±13 years, (59) 31% males]. Patients with positive mepolizumab ...